The much-anticipated reporting season is critical to understanding the direction of the market over the next 12 months, and could not have come at a more interesting time with the Australian market recently making a new all-time high.
Shares
Watch out if you want income from health care or technology shares. The Australian sharemarket is one of the highest dividend payers in the world but not all sectors are equal where dividends are concerned.
Ross McEwan will take over as NAB CEO no later than April 2020, but it's difficult to see how he can change the bank's profitability problems.
The US remains the world's largest medical device market with no signs of slowing, and Boston Scientific is at the forefront of the ultra-competitive industry.
While miners led the corporate reporting season, which is currently underway in Australia, what can we expect across the broader market?
A growing focus on the medicinal benefits of cannabis-derived drugs could spark up the industry as demand for cannabis stocks soars.
Not often mentioned despite being in the ASX100, Iluka Resources receives an extremely lucrative royalty rate on iron ore revenue generated from BHP's Area C mine.
The collections plate is becoming a thing of the past, with New Zealand-born app Pushpay processing $US4.2 billion in church tithing in 12 months.
Emily wants to diversify into ETFs, but feels guilty that she didn't do it in 2018 because they have jumped so much in price.
AGL has gone from being an enthusiastic buyer of Vocus to walking out the data room without a glance back. Were they forced to repent by angry shareholders?
